Korean J Med.
1999 Jan;56(1):25-32.
Cardiovascular Regulation of GABAB Receptor in the Spinal Cord of the Rats
- Affiliations
-
- 1Department of Internal Medicine, college of medicine, Sung Kyun Kwan University Samsung Medical Center, Seoul, Korea.
Abstract
OBJECTIVES
The purpose of present study is to investigate the influence of a spinal
gamma-aminobutyric acid B (GABAB) receptor on a central regulation of blood pressure(BP) and
heart rate(HR), and to define its mechanism in the spinal cord.
METHODS
In urethane-anesthetized, d-tubocurarine- paralyzed and artificially ventilated male
Sprague-Dawley rats, intrathecal administration of drugs were carried out using injecton
cannula(33-gauge stainless steel) through the guide cannula(PE 10) which was inserted
intrathecally at lower thoracic level through the puncture of a atlantooccipital membrane.
RESULTS
Intrathecal injection of an GABAB receptor agonist baclofen(30, 60, 100 nmol)
decreased both blood pressure and heart rate dose-dependently. Pretreatment with
8-bromo-cAMP(50 nmol), a cAMP analog or glipizide(50 nmol), a ATP-sensitive K+ channel blocker
attenuated the depressor and bradycardic effects of baclofen (100 nmol) but not with
8-bromo-cGMP(50 nmol) a cGMP analog.
CONCLUSIONS
The GABAB receptor in the spinal cord plays an inhibitory role in central
cardiovascular regulation and that this depressor and bradycardic actions are mediated by the
decrease of cAMP via the inhibition of adenylate cyclase and the opening of K+ channel.